Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | SRC | P12931 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 8/20 | 0.43 |
| ▸ | CA1 | P00915 | 7/20 | 0.43 |
| ▸ | CA9 | Q16790 | 7/20 | 0.43 |
| ▸ | CA4 | P22748 | 7/20 | 0.43 |
| ▸ | CA5A | P35218 | 7/20 | 0.43 |
| ▸ | CA12 | O43570 | 6/20 | 0.43 |
| ▸ | CA7 | P43166 | 6/20 | 0.43 |
| ▸ | CA5B | Q9Y2D0 | 6/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9165442 | 0.98 | L3MBTL1 (0.54) | L3MBTL1TDP1ALDH1A1SRCCA2 | |
| SCHEMBL35394 | 0.91 | L3MBTL1 (0.60) | L3MBTL1TDP1ALDH1A1SRCCA2 | |
| SCHEMBL331195 | 0.87 | L3MBTL1 (0.67) | L3MBTL1TDP1ALDH1A1SRCCA2 | |
| SCHEMBL9163448 | 0.85 | L3MBTL1 (0.54) | L3MBTL1TDP1ALDH1A1SRCCA2 | |
| SCHEMBL29207963 | 0.85 | L3MBTL1 (0.64) | L3MBTL1TDP1ALDH1A1SRCCA2 | |
| Phosphine SCHEMBL28875449 | 0.85 | L3MBTL1 (0.64) | L3MBTL1TDP1ALDH1A1SRCCA2 | |
| SCHEMBL20710845 | 0.82 | L3MBTL1 (0.50) | L3MBTL1TDP1ALDH1A1SRCCA2 | |
| SCHEMBL20643973 | 0.82 | HPGD (0.53) | L3MBTL1TDP1ALDH1A1SRCCA2 | |
| SCHEMBL28388435 | 0.82 | TDP1 (0.50) | L3MBTL1TDP1ALDH1A1SRCCA2 | |
| SCHEMBL17491592 | 0.82 | CYP3A4 (0.57) | L3MBTL1TDP1ALDH1A1CA2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10818845-B2 | Organic electronic device | NOVALED GMBH (DE) | 2020-10-27 | — | — | US | disclosed |
| US-10818845-B2 | Organic electronic device | NOVALED GMBH (DE) | 2020-10-27 | — | — | US | disclosed |
| US-20190312208-A1 | Organic Electronic Device | NOVALED GMBH (DE) | 2019-10-10 | — | — | US | disclosed |
| US-20190312208-A1 | Organic Electronic Device | NOVALED GMBH (DE) | 2019-10-10 | — | — | US | disclosed |
| US-10374165-B2 | Organic electronic device | NOVALED GMBH (DE) | 2019-08-06 | — | — | US | disclosed |
| US-10374165-B2 | Organic electronic device | NOVALED GMBH (DE) | 2019-08-06 | — | — | US | disclosed |
| EP-2786434-B1 | ORGANIC ELECTRONIC DEVICE | NOVALED GMBH (DE) | 2015-09-30 | — | — | EP | disclosed |
| US-20140353649-A1 | Organic Electronic Device | NOVALED GMBH (DE) | 2014-12-04 | — | — | US | disclosed |
| US-20140353649-A1 | Organic Electronic Device | NOVALED GMBH (DE) | 2014-12-04 | — | — | US | disclosed |
| US-20140353649-A1 | Organic Electronic Device | NOVALED GMBH (DE) | 2014-12-04 | — | — | US | disclosed |
| EP-2786434-A1 | ORGANIC ELECTRONIC DEVICE | Novaled GmbH (DE) | 2014-10-08 | — | — | EP | disclosed |
| WO-2013079678-A1 | ORGANIC ELECTRONIC DEVICE | NOVALED AG (DE) | 2013-06-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10374165-B2 | Organic electronic device | SCO2, AOC2, AOC3 | L3MBTL1 294/4885TDP1 3270/4885ALDH1A1 97/4885 |
| US-10818845-B2 | Organic electronic device | SCO2, AOC2, AOC3 | L3MBTL1 294/4885TDP1 3270/4885ALDH1A1 97/4885 |
| US-20190312208-A1 | Organic Electronic Device | SCO2, AOC2, AOC3 | L3MBTL1 294/4885TDP1 3270/4885ALDH1A1 97/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.